| Copper | Approved Investigational | PAPPA2 | 60676 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of PAPPA2 mRNA | 1q25.2 | |
| Copper | Approved Investigational | PAPSS2 | 9060 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of PAPSS2 mRNA | 10q23.2-q23.31 | |
| Copper | Approved Investigational | PARD6B | 84612 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of PARD6B mRNA | 20q13.13 | |
| Copper | Approved Investigational | PARP1 | 142 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of PARP1 mRNA | 1q42.12 | |
| Copper | Approved Investigational | PATZ1 | 23598 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of PATZ1 mRNA | 22q12.2 | |
| Copper | Approved Investigational | PAXIP1 | 22976 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of PAXIP1 mRNA | 7q36.2 | |
| Copper | Approved Investigational | PBK | 55872 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of PBK mRNA | 8p21.1 | |
| Copper | Approved Investigational | PBX1 | 5087 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of PBX1 mRNA | 1q23.3 | |
| Copper | Approved Investigational | PCDH18 | 54510 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of PCDH18 mRNA | 4q28.3 | |
| Copper | Approved Investigational | PCDH7 | 5099 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of PCDH7 mRNA | 4p15.1 | |
| Copper | Approved Investigational | PCK2 | 5106 |
upregulated | [Disulfiram binds to Copper] which results in increased expression of PCK2 mRNA | 14q11.2-q12 | |
| Copper | Approved Investigational | PCK2 | 5106 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of PCK2 mRNA | 14q11.2-q12 | |
| Copper | Approved Investigational | PCLAF | 9768 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of PCLAF mRNA | 15q22.31 | |
| Copper | Approved Investigational | PCNA | 5111 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of PCNA mRNA | 20p12.3 | |
| Copper | Approved Investigational | PCNX4 | 64430 |
upregulated | [Disulfiram binds to Copper] which results in increased expression of PCNX4 mRNA | 14q23.1 | |
| Copper | Approved Investigational | PCSK9 | 255738 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of PCSK9 mRNA | 1p32.3 | |
| Copper | Approved Investigational | PDE3B | 5140 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of PDE3B mRNA | 11p15.2 | |
| Copper | Approved Investigational | PDE5A | 8654 |
upregulated | [Disulfiram binds to Copper] which results in increased expression of PDE5A mRNA | 4q26 | |
| Copper | Approved Investigational | PDE5A | 8654 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of PDE5A mRNA | 4q26 | |
| Copper | Approved Investigational | PDGFA | 5154 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of PDGFA mRNA | 7p22.3 | |
| Copper | Approved Investigational | PDGFC | 56034 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of PDGFC mRNA | 4q32.1 | |
| Copper | Approved Investigational | PDGFRA | 5156 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of PDGFRA mRNA | 4q12 | |
| Copper | Approved Investigational | PDGFRB | 5159 |
upregulated | [Disulfiram binds to Copper] which results in increased expression of PDGFRB mRNA | 5q32 | |
| Copper | Approved Investigational | PDLIM5 | 10611 |
upregulated | [Disulfiram binds to Copper] which results in increased expression of PDLIM5 mRNA | 4q22.3 | |
| Copper | Approved Investigational | PDP1 | 54704 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of PDP1 mRNA | 8q22.1 | |